InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,724.80
(
0.01%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
82.91
(
-0.37%
)
Bitcoin
61,833.14
(
-1.70%
)
Post# of 287
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dr Jerry

Send PM Follow Ignore
Followers 121
Posts 2016
Boards Moderated 0
Alias Born 11/20/2012

Dr Jerry

Re: cjstocksup post# 179

Monday, 09/18/2017 12:49:42 PM

Monday, September 18, 2017 12:49:42 PM

Post# of 287
News from FIbrolamellar hepatic cancer trial shows 2076 is increasing PFS well above expectations as Casi has identified the genetic marker that responds to their aurora kinase inhibitor.
The other major responses is in triple negative breast cancer for which Casi has also identified a genetic marker.
CASI may get compassionate approval
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CASI News
More CASI News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!